GoodRx Holdings (GDRX) Total Debt (2019 - 2026)

GoodRx Holdings has disclosed Total Debt across 8 years of filings, most recently posting $486.6 million for Q2 2026.

• In Q2 2026, Total Debt fell 0.69% year-over-year to $486.6 million; the TTM figure through Jun 2026 stood at $486.6 million (down 0.69% YoY), while the FY2025 annual figure was $488.3 million, down 0.7% from the prior year.
• Total Debt came in at $486.6 million for Q2 2026 at GoodRx Holdings, roughly flat from $487.4 million in the prior quarter.
• In the past five years, Total Debt ranged from a high of $661.9 million in Q1 2022 to a low of $486.6 million in Q2 2026.
• Average Total Debt over 5 years is $582.8 million, with a median of $653.2 million recorded in 2024.
• Year-over-year, Total Debt retreated 0.35% in 2023 and declined 25.1% in 2024.
• Over 5 years, Total Debt stood at $658.8 million in 2022, then fell by 0.35% to $656.5 million in 2023, then decreased by 25.1% to $491.7 million in 2024, then retreated by 0.7% to $488.3 million in 2025, then decreased by 0.34% to $486.6 million in 2026.
• Per Business Quant data, the three most recent Total Debt figures were $486.6 million in Q2 2026, $487.4 million in Q1 2026, and $488.3 million in Q4 2025.